EHF anticorps
-
- Antigène Voir toutes EHF Anticorps
- EHF (Ets Homologous Factor (EHF))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp EHF est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- Immunogen affinity purified
- Pureté
- ≥95 % as determined by SDS-PAGE
- Immunogène
- ets homologous factor
- Isotype
- IgG
- Top Product
- Discover our top product EHF Anticorps primaire
-
-
- Indications d'application
- WB: 1:500-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
- Date de péremption
- 12 months
-
- Antigène
- EHF (Ets Homologous Factor (EHF))
- Autre désignation
- EHF (EHF Produits)
- Synonymes
- anticorps zgc:136967, anticorps ESE3, anticorps ESE3B, anticorps ESEJ, anticorps 9030625L19Rik, anticorps AU019492, anticorps ets homologous factor, anticorps ETS homologous factor, anticorps ehf, anticorps EHF, anticorps Ehf
- Sujet
- Synonyms:ESE3, ESE3B, Background:Transcriptional activator that may play a role in regulating epithelial cell differentiation and proliferation. May act as a repressor for a specific subset of ETS/AP-1-responsive genes and as a modulator of the nuclear response to mitogen-activated protein kinase signaling cascades. Binds to DNA sequences containing the consensus nucleotide core sequence GGAA. Involved in regulation of TNFRSF10B/DR5 expression through Ets-binding sequences on the TNFRSF10B/DR5 promoter. May contribute to development and carcinogenesis by acting as a tumor suppressor gene or anti-oncogene.
- Poids moléculaire
- 35 kDa
- ID gène
- 26298
- UniProt
- Q9NZC4
-